Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
Bénédicte Delire, Peter Stärkel, Isabelle Leclercq
[ Html ]
[ PDF ] 53-66
doi:10.14218/JCTH.2014.00035
Chronic Hepatitis C Infection in Children: Current Treatment and New Therapies
Andrew Lee, Jeremy Rajanayagam, Mona Abdel-Hady
[ Html ]
[ PDF ] 36-41
doi:10.14218/JCTH.2014.00036
Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy
Qing-Qing Zhang, Lun-Gen Lu
[ Html ]
[ PDF ] 78-84
doi:10.14218/JCTH.2014.00037
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
Thomas McQuaid, Carolyn Savini, Star Seyedkazemi
[ Html ]
[ PDF ] 27-35
doi:10.14218/JCTH.2014.00041
Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
Evan J. Raff, Donny Kakati, Joseph R. Bloomer, Mohamed Shoreibah, Khalid Rasheed, Ashwani K. Singal
doi:10.14218/JCTH.2015.00001
Mesenchymal Bone Marrow-derived Stem Cells Transplantation in Patients with HCV Related Liver Cirrhosis
Sviatlana P. Lukashyk, Vladimir M. Tsyrkunov, Yanina I. Isaykina, Oksana N. Romanova, Artur T. Shymanskiy, Olga V. Aleynikova, Rimma I. Kravchuk
[ Html ]
[ PDF ] 217-221
doi:10.14218/JCTH.2014.00027
Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C
Ye-Jiao Wu, Ming-Yi Xu, Lun-Gen Lu
[ Html ]
[ PDF ] 222-227
doi:10.14218/JCTH.2014.00029
Treatment of Hepatitis C Virus Infection in Children Less than 12 Years of Age in Developing Countries
Sina Aziz
[ Html ]
[ PDF ] 247-252
doi:10.14218/JCTH.2014.00034